Literature DB >> 4147427

Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.

B Basil, R Jordan, A H Loveless, D R Maxwell.   

Abstract

1. The beta-adrenoceptor blocking properties of (+/-)-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride (M&B 17,803A) have been compared with those of practolol and propranolol in the guinea-pig, cat and dog.2. Following either intravenous or oral administration in the cat or dog, M&B 17,803A and practolol had similar potency in antagonizing isoprenaline-induced tachycardia and both showed cardioselectivity, but both were less potent than propranolol.3. M&B 17,803A and practolol had approximately one hundredth the intravenous potency of propranolol in increasing the severity of anaphylactic bronchospasm in the conscious sensitized guinea-pig.4. M&B 17,803A possessed less marked intrinsic sympathomimetic activity than practolol but, like propranolol, it had significant local anaesthetic properties and increased the refractory period of rabbit isolated atria.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4147427      PMCID: PMC1776183          DOI: 10.1111/j.1476-5381.1973.tb06906.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Pharmacology of M & B 17803A in man and dog.

Authors:  R H Briant; C T Dollery; T Fenyvesi; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

2.  Comparison of some properties of pronethalol and propranolol.

Authors:  J W Black; W A Duncan; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1965-12

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Another possibly cardioselective beta-blocker.

Authors:  I Roetscher
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

5.  Plasma propranolol levels associated with suppression of ventricular ectopic beats.

Authors:  D J Coltart; D G Gibson; D G Shand
Journal:  Br Med J       Date:  1971-02-27

6.  Evidence for an adrenergic homeostatic bronchodilator reflex mechanism.

Authors:  M W McCulloch; C Proctor; M J Rand
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

7.  Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

Authors:  A G Wilson; O G Brooke; H J Lloyd; B F Robinson
Journal:  Br Med J       Date:  1969-11-15

8.  Comparative chronotropic activity of beta-adrenoceptive antagonists.

Authors:  A M Barrett; J Carter
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

9.  Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.

Authors:  M F Cuthbert; K Owusu-Ankomah
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

10.  Assessment of the effectiveness of -adrenoceptor blocking agents towards cardiac and bronchiolar responses of the pithed guinea-pig to electrical stimulation of the spinal outflow.

Authors:  D T Burden; M W Parkes
Journal:  Br J Pharmacol       Date:  1972-06       Impact factor: 8.739

View more
  29 in total

1.  Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes.

Authors:  H H Harms; J Van der Meer
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

Review 2.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

3.  Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.

Authors:  M F Cuthbert; R F Collins
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

4.  Comparison of the antilipolytic effect of metoprolol, acebutolol, and propranolol in man.

Authors:  R J Newman
Journal:  Br Med J       Date:  1977-09-03

Review 5.  Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.

Authors:  G Cocco; F Burkart; D Chu; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

6.  Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

Authors:  H H Harms; L Gooren; A J Spoelstra; C Hesse; L Verschoor
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

Review 7.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

8.  Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.

Authors:  M K Jones; J Birtwell; D R Owens; G R Jones; M Lewis
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

9.  Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.

Authors:  D O Gibbons; A F Lant; A Ashford; R F Collins; S Pinder
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

10.  Acebutolol in hypertension--double-blind trial against placebo.

Authors:  M A Martin; C A Phillips; A J Smith
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.